Complement in Hemolysis- and Thrombosis- Related Diseases

Front Immunol. 2020 Jul 10:11:1212. doi: 10.3389/fimmu.2020.01212. eCollection 2020.

Abstract

The complement system, originally classified as part of innate immunity, is a tightly self-regulated system consisting of liquid phase, cell surface, and intracellular proteins. In the blood circulation, the complement system, platelets, coagulation system, and fibrinolysis system form a close and complex network. They activate and regulate each other and jointly mediate immune monitoring and tissue homeostasis. The dysregulation of each cascade system results in clinical manifestations and the progression of different diseases, such as sepsis, atypical hemolytic uremic syndrome, C3 glomerulonephritis, systemic lupus erythematosus, or ischemia-reperfusion injury. In this review, we summarize the crosstalk between the complement system, platelets, and coagulation, provide integrative insights into how complement dysfunction leads to hemopathic progression, and further discuss the therapeutic relevance of complement in hemolytic and thrombotic diseases.

Keywords: anti-complement agent; complement; hematological disorder; hematology; platelet.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Blood Coagulation / immunology
  • Blood Platelets / immunology
  • Blood Platelets / metabolism
  • Cell Communication
  • Complement Activation / immunology
  • Complement System Proteins / immunology*
  • Disease Susceptibility / immunology*
  • Hemolysis / immunology*
  • Hemostasis / immunology
  • Humans
  • Thrombosis / blood*
  • Thrombosis / diagnosis
  • Thrombosis / immunology*

Substances

  • Complement System Proteins